49.51
-1.22(-2.40%)
Currency In CNY
Address
Hite Science and Technology Park
Wuhan, 430056
China
Phone
86 27 8489 1666
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1520
First IPO Date
August 08, 2017
Name | Title | Pay | Year Born |
Mr. Ya Chen | Chairman of the Board & GM | 0 | 1972 |
Ms. Han Zhen Xia | Chief Financial Officer | 0 | 1963 |
Mr. Huang Chen | Deputy GM, Secretary & Director | 0 | 1975 |
Wen Xian | Accounting Supervisor & Non-Independent Director | 0 | N/A |
Mr. Sheng Qiang Li | Deputy General Manager | 0 | 1976 |
Wuhan Hiteck Biological Pharma Co.,Ltd, a biopharmaceutical company, engages in the research and development, production, and sale of bio engineering products and freeze-dried powder injection in China. Its products include Jinlujie, a mouse nerve growth factor for injection; omeprazole sodium for injection; cyclic adenosine phosphate; Xinye, an acyclovir dispensable tablets; Bingbing Horse & Dragon, an indomethacin furazolidone suppository drug; Xunkeyuan, a tinidazole suppository drug; and Shufu, a nimodipine sustained release tablets. The company also provides measles virus and rubella virus nucleic acid detection kit; mycoplasma isolation and identification kit and culture tube; bacterial vaginosis rapid detection kit; measles virus IgG antibody detection kit; and coronavirus N-protein detection kit. In addition, it offers Lopinavir and Ritonavir APIs; and intermediates. The company offers its products in the field of nervous system and oncology. Wuhan Hiteck Biological Pharma Co.,Ltd was founded in 1992 and is based in Wuhan, China.